Journal Article

The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases

Rozpędek-Kamińska, Wioletta, Pytel, Dariusz, Majsterek, Ireneusz, Wawrzynkiewicz, Adam, Diehl, J. Alan, Wojtczak, Radosław, Siwecka, Natalia

2020

Overview

Higher prevalence of neurodegenerative diseases is strictly connected with progressive aging of the world population. Interestingly, a broad range of age-related, neurodegenerative diseases is characterized by a common pathological mechanism—accumulation of misfolded and unfolded proteins within the cells. Under certain circumstances, such protein aggregates may evoke endoplasmic reticulum (ER) stress conditions and subsequent activation of the unfolded protein response (UPR) signaling pathways via the protein kinase RNA-like endoplasmic reticulum kinase (PERK)-dependent manner. Under mild to moderate ER stress, UPR has a pro-adaptive role. However, severe or long-termed ER stress conditions directly evoke shift of the UPR toward its pro-apoptotic branch, which is considered to be a possible cause of neurodegeneration. To this day, there is no effective cure for Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), or prion disease. Currently available treatment approaches for these diseases are only symptomatic and cannot affect the disease progression. Treatment strategies, currently under detailed research, include inhibition of the PERK-dependent UPR signaling branches. The newest data have reported that the use of small-molecule inhibitors of the PERK-mediated signaling branches may contribute to the development of a novel, ground-breaking therapeutic approach for neurodegeneration. In this review, we critically describe all the aspects associated with such targeted therapy against neurodegenerative proteopathies.

• Publisher: MDPI AG,MDPI
• Subject: Age / Alzheimer Disease - drug therapy / Alzheimer Disease - metabolism / Animals / Apoptosis / Brain research / Cognitive ability / Dementia / Disease / Dopamine / eIF-2 Kinase - antagonists & inhibitors / eIF-2 Kinase - metabolism / Endoplasmic reticulum / Endoplasmic Reticulum Stress - drug effects / Humans / Huntingtons disease / Kinases / Lipid peroxidation / Memory / Molecular Targeted Therapy / Mutation / Neurodegeneration / Neurodegenerative Diseases - drug therapy / Neurodegenerative Diseases - metabolism / Oxidative stress / Pathogenesis / Population / Protein Kinase Inhibitors - therapeutic use / Proteins / Review / Small Molecule Libraries - therapeutic use / Unfolded Protein Response - drug effects / Vitamin deficiency